We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Test May Replace ELISA for Detecting Antibodies

By LabMedica International staff writers
Posted on 15 Apr 2019
A microwire-based test may replace enzyme-linked immunosorbent assay (ELISA) as the primary method to detect antibodies specific for pathogenic microorganisms in patient's sera.

Detection of viral infection is commonly performed using serological techniques like ELISA to detect antibody responses. More...
Such assays may also be used to determine the infection phase based on isotype (IgG or IgM) prevalence. However, ELISAs demonstrate limited sensitivity and are difficult to perform at the point of care.

Investigators at Colorado State University (Fort Collins, USA) have described a method for detecting antibodies against pathogenic viruses with sensitivity significantly better than ELISA. Their method reportedly enables label-free, rapid detection of ultra-low concentrations of virus specific antibodies.

The simple test comprised a capacitive biosensor that incorporated gold microwires coated with Zika or Chikungunya virus envelope antigen. An electrical current passed through the wire created a charge on the wire. Antibodies from the patient's sample bound to the viral proteins on the wire, which increased the outside mass. In addition, antibody binding increased the ability of the wire to hold the charge. By measuring the change in mass, it was possible to quantify the number of antibodies on the surface of the wire.

The investigators reported that with little discernable nonspecific binding, the sensor could detect as few as 10 antibody molecules in a small volume (30 microliters) of fluid within a few minutes. It could also be used to rapidly, specifically, and accurately determine the isotype of antigen-specific antibodies.

"This type of research project is something that none of us could do on our own," said senior author Dr. Brian Geiss, associate professor of microbiology, immunology, and pathology at Colorado State University. "We synergized our efforts to come up with new solutions to problems we are hoping will eventually be used in clinical settings. We hope that it can be used for point-of-care diagnostics, and that it can be developed into a compact hand-held system that can be used in the clinic or in resource-limited areas."

The microwire antibody detection method was described in the April 15, 2019, issue of the journal Biosensors and Bioelectronics.

Related Links:
Colorado State University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
All-in-One Molecular System
AIO M160
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.